Angiochem is a clinical-stage biotechnology company discovering and developing novel drugs that are crossing the blood-brain barrier to treat brain diseases. These new Engineered Peptide Compounds (EPiC) have the potential to address significant medical needs, many of which cannot be effectively addressed due to the fundamental physiological challenge the blood-brain barrier presents for therapeutic intervention. Angiochem is developing a deep and broad product pipeline, including small and large molecules, for the treatment of a wide range of brain diseases including brain cancers, lysosomal storage disorders, pain and others. The EPiC platform has been strongly validated in humans.
View Top Employees from AngiochemWebsite | http://www.angiochem.com |
Revenue | $5 million |
Funding | $7.5 million |
Employees | 10 (8 on RocketReach) |
Founded | 2003 |
Address | 4150 St Catherine St West, Ste 490, Westmount, Quebec H3Z 2Y5, CA |
Phone | (514) 788-7800 |
Fax | (514) 700-2166 |
Technologies |
JavaScript,
Google Analytics,
Nginx
+4 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Biotechnology Research, Healthcare, Science and Engineering, Drug Manufacturing & Research, Health Care, Health Diagnostics |
Web Rank | 27 Million |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Angiochem employee's phone or email?
The Angiochem annual revenue was $5 million in 2023.
8 people are employed at Angiochem.
Angiochem is based in Westmount, Quebec.
The NAICS codes for Angiochem are [32541, 32, 325, 3254].
The SIC codes for Angiochem are [28, 283].